Stay updated on Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a revision update: v3.3.2 replaces v3.3.1, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublication section wording updated to indicate that publications are automatically filled from PubMed, a public database, and may not all be about the study. The version reference updated to v3.3.1, replacing v3.2.0.SummaryDifference0.1%

- Check29 days agoChange DetectedA government funding notice banner about potential updates and NIH operations was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedNo substantive changes detected in the study record; the title, conditions, eligibility criteria, study design, primary and secondary outcomes, and locations appear unchanged from the prior version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedPage update adds version v3.1.0 and removes several substantive drug-safety topics and a prior version note.SummaryDifference0.5%

Stay in the know with updates to Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.